Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
ViiV Steals A March On Gilead with HIV Doublet Data
Jul 24 2018
•
By
Sten Stovall
ViiV's GEMINI 1 & 2 studies met their primary endpoint in HIV • Source: Shutterstock
More from Clinical Trials
More from R&D